Targeting the ubiquitin proteasome pathway for the treatment of septic shock in patients

AUTOR(ES)

Brun, Jan

FONTE

BioMed Central

RESUMO

Endotoxic shock is a serious systemic inflammatory response to an external biological stressor. The responsiveness of NF-κB is built upon rapid protein modification and degradation involving the ubiquitin proteasome pathway. Using transgenic mice, we have obtained in vivo evidence that interference with this pathway can alleviate the symptoms of toxic shock. We posit that administration of proteasome inhibitors may enhance the survival of patients with septic shock.

Documentos Relacionados

• Phosphorylation-dependent targeting of cAMP response element binding protein to the ubiquitin/proteasome pathway in hypoxia
• Heat Shock Response and Protein Degradation: Regulation of HSF2 by the Ubiquitin-Proteasome Pathway
• In vivo function of the proteasome in the ubiquitin pathway.
• The Ubiquitin-Proteasome Pathway and Plant Development
• The role of the ubiquitination-proteasome pathway in breast cancer: Applying drugs that affect the ubiquitin-proteasome pathway to the therapy of breast cancer